drugset / Trial / NCT01162473

Milk Oral Immunotherapy in Children to Treat Food Allergy

NCT01162473 ↗

Phase 0 Completed 25 enrolled Children's Hospital of Philadelphia
RandomizedParallel-groupTriple-blindTreatment

Summary

Background and Rationale For patients with Immunoglobulin E (IgE)-mediated food allergy, the current management includes identification of the causative food and avoidance. Specifically, among young children, cow's milk allergy is the most common food allergy, occurring in as many as 2-3%. Given the prevalence of milk and the difficulty to avoid it in the diet, the investigators aim to investigate the safety and efficacy of oral immunotherapy for cow's milk allergy. Main Objective The primary objective is to study the efficacy of milk oral immunotherapy. Target Population Children aged six to 17 years with a history of cow's milk allergy will be recruited from The Children's Hospital of Philadelphia Allergy clinical offices for the investigators study.

Timeline

Start
2010-06
Primary completion
2013-12
Completion
2013-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Milk protein powder Protein / enzyme biologic 8 unknown Oral

Indications

No indication recorded.